Last updated: 20 June 2019 at 2:43am EST

Stein Jacobsen Net Worth




The estimated Net Worth of Stein Jacobsen is at least $19.3 millió dollars as of 23 November 2011. Stein Jacobsen owns over 9,195 units of Resmed stock worth over $13,188,008 and over the last 15 years Stein sold RMD stock worth over $6,137,892.

Stein Jacobsen RMD stock SEC Form 4 insiders trading

Stein has made over 5 trades of the Resmed stock since 2009, according to the Form 4 filled with the SEC. Most recently Stein sold 9,195 units of RMD stock worth $232,450 on 23 November 2011.

The largest trade Stein's ever made was selling 87,722 units of Resmed stock on 12 November 2010 worth over $2,915,002. On average, Stein trades about 20,935 units every 93 days since 2009. As of 23 November 2011 Stein still owns at least 52,143 units of Resmed stock.

You can see the complete history of Stein Jacobsen stock trades at the bottom of the page.



What's Stein Jacobsen's mailing address?

Stein's mailing address filed with the SEC is RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123.

Insiders trading at Resmed

Over the last 23 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace és David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.



What does Resmed do?

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.



Complete history of Stein Jacobsen stock trades at Resmed

Az érdekelt
Trans.
Tranzakció
Teljes ár
Stein Jacobsen
COO és Europe
Eladás $232,450
23 Nov 2011
Stein Jacobsen
COO és Europe
Eladás $2,915,002
12 Nov 2010
Stein Jacobsen
COO és Europe
Opció Gyakorlat $1,005,065
12 Feb 2010
Stein Jacobsen
COO és Europe
Eladás $2,000,000
17 Nov 2009
Stein Jacobsen
COO és Europe
Eladás $990,440
10 Aug 2009


Resmed executives and stock owners

Resmed executives and other stock owners filed with the SEC include: